{
    "eid": "2-s2.0-84920169759",
    "title": "Population pharmacokinetics of nevirapine in Thai HIV-infected patients",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [],
    "authors": [
        "Thanaporn Wattanakul"
    ],
    "citedby-count": 3,
    "ref-count": 43,
    "ref-list": [
        "Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010",
        "Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR\u00ae) for the treatment of advanced HIV-infected patients: A 24-week study",
        "Nevirapine- versus efavirenz-based highly acitve antiretroviral therapy regimens in antiretroviral-na\u00efve patients with advanced HIV infection",
        "The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand",
        "The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-na\u00efve adult HIV patients",
        "Practical guidelines to interpret plasma concentrations of antiretroviral drugs",
        "Pharmacokinetics of nevirapine: Initial single-rising-dose study in humans",
        "Disposition and biotransformation of the antiretroviral drug nevirapine in humans",
        "Nevirapine: A review of its development, pharmacological profile and potential for clinical use",
        "Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study",
        "Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients",
        "Once- or twice-daily dosing of nevirapine in HIV-infected adults: A population pharmacokinetics approach",
        "Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals",
        "Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals",
        "Integration of population pharmacokinetics and pharmacogenetics: An aid to optimal nevirapine dose selection in HIV-infected individuals",
        "Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: A population approach",
        "Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected cambodian patients",
        "An introduction to mixed effect modeling: Concepts, definitions, and justification",
        "Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population",
        "High-dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection",
        "High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals",
        "Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy",
        "Pharmacokinetics of nevirapine: Once-daily versus twice-daily dosing in the 2NN study",
        "Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin",
        "Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole",
        "Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin",
        "Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography",
        "Evaluation of antiretroviral drug measurements by an interlaboratory quality control program",
        "Xpose - An S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM",
        "A size standard for pharmacokinetics",
        "Model appropriateness and population pharmacokinetic modeling",
        "Some suggestions for measuring predictive performance",
        "STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT",
        "Integration of data from multiple sources for simultaneous modelling analysis: Experience from nevirapine population pharmac okinetics",
        "Nuclear receptor-mediated induction of CYP450 by antiretrovirals: Functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans",
        "Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins",
        "Frequency of genetic polymorphisms of PXR gene in the Brazilian population",
        "Identification of NR1I2 genetic variation using resequencing",
        "Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4",
        "Single nucleotide polymorphisms of the pregnane X receptor gene in Han Chinese and a comparison with other ethnic populations",
        "Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression",
        "PXR: A xenobiotic receptor of diverse function implicated in pharmacogenetics",
        "PXR variants and artemisinin use in vietnamese subjects: Frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nontaburi",
            "affilname": "Bamrasnaradura Infectious Diseases Institute",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}